Hexima Share Price and Company Fundamentals
Last traded: Today at 5:36 AM
Hexima Limited, a biotechnology company, engages in the research and development of plant-derived proteins and peptides for applications as human therapeutics. The company's lead drug candidate is the plant defensin, pezadeftide, which is in phase IIb clinical trials for the treatment of fungal toenail infections in Australia and New Zealand. The company was incorporated in 1997 and is headquartered in Melbourne, Australia.
|Primary activities||Research and development of plant-derived proteins and peptides for applications as human therapeutics.|
|Industry / Sector||Biotechnology / Healthcare|
|Mailing address||La Trobe Institute for Molecular Science Level 4,LIMS 2 La Trobe University Melbourne VIC 3086 Australia|
|Phone / Fax||61 3 9479 1210 /|
|Share registry||LINK MARKET SERVICES LIMITED|
Hexima paid $0.00 dividend and the ex-dividend date was .The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.HXL dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
HXL's forward dividend amount is $ and the forward dividend yield is . A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.
As of Aug 2022, following are the company executives and directors listed on Hexima.
|Dr. Nicole van der Weerden B.Sc., BSc (Hons), MBA (MBS), Ph.D.||Acting CEO, COO & Exec. Director||470.41k|
|Ms. Helen Molloy||Financial Controller||192.85k|
|Prof. Marilyn A. Anderson AO, B.Sc., BSc (Hons), FAA, FAICD, FT||Chief Science Officer||70||100.93k|
|Dr. Peter J. Welburn Ph.D.||Consultant||69||140.94k|
|Dr. Neil Forrester||VP of Bus. Devel.|
|Dr. Nancy Sacco||Chief Devel. Officer|
|Mr. Phillip J. Rose R. Ph, R.Ph.||Chief Commercial Officer||67|
|Ms. Leanne Ralph||Company Sec.|
|Prof. Adrienne Elizabeth Clarke||Science Advisor||83|
Profitability and management effectiveness
Return on assets
Return on equity
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Hexima is and its enterprise value is .
Companies similar to Hexima (HXL)
Hexima (ASX:HXL) Frequently Asked Questions
1. What is Hexima's Stock Symbol?
Hexima trades on ASX under the ticker symbol "HXL".
2. What is Hexima's stock price today?
One share of HXL stock can currently be purchased for approximately $0.012.
3. How can I contact Hexima?
Hexima's mailing address is La Trobe Institute for Molecular Science Level 4,LIMS 2 La Trobe University Melbourne VIC 3086 Australia. The company can be reached via phone at 61 3 9479 1210.
4. What is Hexima's official website?
The official website of Hexima is https://www.hexima.com.au.
5. Which share registry manages Hexima's stock?
Hexima's stock is managed by LINK MARKET SERVICES LIMITED.